Location: Home
  • search
  • go
  • Relate News
  • 12/13/2022China to Roll Out Second COVID Vaccine Booster for High-risk Groups, E...
  • 12/13/2022CNIPA Issued Promotion Plan To Strengthen IP Protection (Mondaq)
  • 12/13/2022The "Unofficial" CN Orange Book User Guide For Pharmaceutical Patents ...
  • 12/13/2022Financing Rebounds for Chinese Drugmakers in November
  • 12/12/2022IQVIA: Chinese Retail Pharmacy Sales down 3.6% in MAT Q3/2022
  • 12/12/2022Sinohealth: Drug Sales of Chinese Retail Pharmacy Sector Up 3.8% in Fi...
  • 12/9/2022China Cracks Down on Drug Price Gouging amid Fears of COVID Spike: Reu...
  • 12/9/2022Drug R&D and Product Registration News Digest December 2022 (1)
  • 12/8/2022Sinopharm Considering Bid to Take China TCM for $4B: Bloomberg
  • 12/8/2022China's Reversal of Zero-Covid Policy to Boost Its Healthcare Sector: ...
  • 12/8/2022November Sees Several Approvals for China-developed Drugs (PharmaDJ)
  • 12/7/202254 Drugs Greenlighted Since Conditional Approval Implemented in China ...
  • 12/6/2022NHSA Announces Postponement of On-Site Negotiations for the 2022 NRDL
  • 12/6/2022Summit and Akeso Reached ~$5B In-License Deal for Breakthru Innovative...
  • 12/5/2022Incyte Forms Partnership with CMS for Ruxolitinib Cream in Greater Chi...
  • 12/5/2022Joint Fight Against Cancer Can Help Re-Energize U.S.-China Ties: Asia ...
  • 12/2/2022CDE Issues Notice on Requirements for e-Submission of Drug Registratio...
  • 12/2/2022Catalent Expands Clinical Supply Facility in China's FTZ
  • 12/2/2022HanAll's Licensed Partner in China Enters Sublicense Agreement with CS...
  • 12/2/2022Recent Executive Moves
  • 12/2/2022China's Challenge in the Drug Services Field (C&EN)
  • 12/1/2022A Growing Number of Drugmakers in China Are on A Quest to Treat NASH (...
  • 12/1/2022Eli Lilly Dumps Innovent's PD-1 after FDA Rebuff (FiercePharma)
  • 12/1/2022NMPA Solicits Comments on the Provisions on Facilitating Main Responsi...
  • 11/30/2022WuXi STA Launches Another Parenteral Formulation Manufacturing Line at...
  • 11/30/2022NMPA Issues Appendix 6 for Quality Control of Drug Retail Delivery of ...
  • 11/30/2022NMPA Issues the Announcement on Implementation of Electronic Submissio...
  • 11/30/2022NMPA Issues the List of Drugs Prohibited for Online Sales (Unofficial ...
  • 11/30/2022NMPA Issues the Announcement on Regulating the Filing and Reporting of...
  • 11/30/2022XJTLU and University of Liverpool to Inaugurate Joint Pharma R&D Cente...
  • Page:119/775 Total number of articles:23233: [First][<<] [117] [118] [119] [120] [121] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group